ENSAL

Main information

  • Trade name:
  • ENSAL ENTERIC MIXTURE
  • Pharmaceutical form:
  • ORAL SOLUTION/SUSPENSION
  • Units in package:
  • 120mL
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ENSAL ENTERIC MIXTURE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY
  • Therapeutic area:
  • antibiotic
  • Therapeutic indications:
  • INFECTIONS OF THE GASTROINTESTINAL TRACT
  • Product summary:
  • An aid in the treatment of bacterial infections of the gastrointestinal tract in dogs and cats caused by organisms susceptible to phthalylsulfathiazole..

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 36286/57182
  • Authorization date:
  • 08-08-2012
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

ENSAL ENTERIC MIXTURE

July 2012

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

ENSAL

ENTERIC MIXTURE

Each 5 mL contains:

250 mg PHTHALYLSULFATHIAZOLE

500 mg KAOLIN-LIGHT

1 mg HYOSCINE METHOBROMIDE

25 mg MONOSODIUM GLUTAMATE

50 mg POTASSIUM GLUCONATE

100 mg CALCIUM GLUCONATE

120 mL [5L]

[Jurox logo]

Side panel

INDICATIONS:

An aid in the treatment of bacterial infections of the gastrointestinal tract in dogs and cats

caused by organisms susceptible to phthalylsulfathiazole.

DIRECTIONS FOR USE:

Dogs: 5 mL per 5 kg bodyweight orally 4 times daily.

Cats: 2.5 mL – 5mL orally 4 times daily

FIRST AID: If poisoning occurs, contact a doctor or Poisons Information Centre. Phone

Australia 131126.

[120 mL pack size]

Dispose of empty container by wrapping with paper and putting in garbage.

[5L pack size]

Triple or (preferably) pressure rinse container before disposal. Dispose of rinsate or any

undiluted chemical according to State/Territory legislative requirements. If not recycling, break,

crush or puncture and deliver empty packaging to an approved waste management facility. DO

NOT burn empty containers or product.

STORE below 25°C (Air Conditioning)

Jurox Pty Limited

85 Gardiner Street

Rutherford, NSW 2320

EXP:

Infoline: 1800 023 312

APVMA 36286/57182

RLP

APPROVED

Infopest

Verified

3-1-2019

Loblaw Companies Limited recalls Life at Home 50 Count Indoor LED Microdot Icicle Lights

Loblaw Companies Limited recalls Life at Home 50 Count Indoor LED Microdot Icicle Lights

Due to a potential manufacturing defect the lights may overheat, posing a burn and fire hazard.

Health Canada

22-11-2018

Safety and efficacy of Monteban® G100 (narasin) for ducks for fattening

Safety and efficacy of Monteban® G100 (narasin) for ducks for fattening

Published on: Wed, 21 Nov 2018 Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of Monteban® G100 for ducks. Monteban® G100, containing narasin, is intended for the prevention of coccidiosis in ducks for fattening at a dose range of 60–70 mg/kg of complete feed. Narasin from Monteban® G100 is safe for ducks for fattening at a level of 70 mg/kg complete feed...

Europe - EFSA - European Food Safety Authority Publications

21-11-2018

Safety and efficacy of Monteban® G100 (narasin) for chickens for fattening

Safety and efficacy of Monteban® G100 (narasin) for chickens for fattening

Published on: Tue, 20 Nov 2018 The feed additive Monteban® G100, containing the active substance narasin, an ionophore anticoccidial, is intended to control coccidiosis in chickens for fattening at a dose of 60–70 mg/kg complete feed. Narasin is produced by fermentation. Limited data on the taxonomic identification of the production strain did not allow the proper identification of strain NRRL 8092 as Streptomyces aureofaciens. The FEEDAP Panel cannot conclude on the absence of genetic determinants for ...

Europe - EFSA - European Food Safety Authority Publications

9-11-2018

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Published on: Wed, 07 Nov 2018 00:00:00 +0100 The EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP Panel) assessed the safety of the additive Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials. It is a family of mixtures combining the four lanthanides lanthanum (La), europium (Eu), gadolinium (Gd) and/or terbium (Tb) in different proportions as their 1,4‐benzene dicarboxylate complexes, used as a taggant in plastics for authentication and ...

Europe - EFSA - European Food Safety Authority Publications

26-11-2018

Today, #FDA’s device center also posted performance report highlighting measures taken to increase predictability, transparency of 510(k) review process, incl. 50 final guidance documents on important medical device policy issues issued since 2009.  https

Today, #FDA’s device center also posted performance report highlighting measures taken to increase predictability, transparency of 510(k) review process, incl. 50 final guidance documents on important medical device policy issues issued since 2009. https

Today, #FDA’s device center also posted performance report highlighting measures taken to increase predictability, transparency of 510(k) review process, incl. 50 final guidance documents on important medical device policy issues issued since 2009. https://go.usa.gov/xPHdn 

FDA - U.S. Food and Drug Administration